Pfizer's Jeffrey Kindler - CEO Pay
Jeffrey Kindler - Pfizer
Total Compensation: $12.6M
2007 Revenue: $48.6B
2006 Revenue: $48.3B
Change: .6%
Details: 2007 was not Pfizer's best year, seeing that the company started things off with one of the biggest drug development flops in recent history. CEO Jeffrey Kindler's pay is low when compared to rivals, but it was still up significantly from $9.8 million in 2006. Kindler pulled in $1.35 million in base pay, $3.1 million in cash bonuses (down slightly from 2006), $7.5 million in stock and options. His other compensation included $175,000 for aircraft use and over $42,000 for his use of a car.
Pfizer News:
Woe is Pfizer, analysts say
Investors, analysts not impressed with Pfizer
Is Pfizer's CEO as bold as promised?
Pfizer chiefs sees pay decline
Pfizer's Kindler leaves analysts feeling flat
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: